UBS AG has increased its price target for Rheinmetall from 570 to 630 euros while maintaining a "Neutral" rating. The adjustment reflects a balance between potential benefits from NATO's defense spending goals and the possibility of a ceasefire in Ukraine, according to analyst Sven Weier.
18:57 25.11.2024
Tesla's stock has surged by over $350 billion since the election, driven more by market enthusiasm than actual business improvements, according to UBS analysts. They caution that potential policy changes, such as the removal of consumer tax credits, could negatively impact Tesla, and maintain a sell rating with a price target increase to $226.
18:54 25.11.2024
The Cabinet has approved waiving bank guarantee requirements for telecom operators on spectrum purchases made before 2022, providing significant relief to Vodafone Idea, which owes over Rs 24,700 crore to the government. This decision aims to alleviate financial stress in the telecom sector and enhance cash flow for operators, facilitating greater investment in network expansion. The move follows earlier reforms that removed BG requirements for future spectrum acquisitions, addressing concerns raised by the Cellular Operators Association of India.
Former Bank of England policymaker Gertjan Vlieghe criticized Governor Andrew Bailey for stifling essential discussions on the future of interest rates. Vlieghe emphasized the need for rate-setters to determine when to halt rate cuts, as current borrowing costs have decreased from 5.25% to 4.75%, with expectations of further reductions to 4% by the end of 2025.
UBS analysts predict Tesla stock could drop 35% due to a lack of fundamental support for its recent surge, maintaining a "sell" rating with a price target of $226. The company's ambitious growth targets, including delivering 15 million cars by 2030, appear unrealistic compared to Wall Street's forecasts. Concerns also arise from Tesla's auto business constituting only 12% of its market cap, historically signaling potential corrections.
18:45 25.11.2024
UBS has maintained a "Neutral" rating for Schott Pharma AG, setting a target price of €32.60 ahead of the 2023/24 financial year results. Analyst Olivier Calvet anticipates a gradual recovery in the company's mass business, which constitutes about half of its sales, in 2025.
18:43 25.11.2024
A group of creditors, including Apollo Global Management Inc. and Monarch Alternative Capital, has initiated confidential discussions with CommScope Holding Co. regarding a potential extension of debt maturities. These talks are conducted under nondisclosure agreements, allowing for the exchange of private information.
Brussels is set to reduce green regulations to bolster Europe's struggling economy, while BusinessEurope expresses concerns that a potential Trump victory could harm green exports due to proposed import tariffs, limiting U.S. market access and intensifying competition with China. Meanwhile, an EU fraud investigation into a €46 million waste treatment project in Cyprus faces bureaucratic delays, raising issues for Costas Kadis as he prepares for his role as EU commissioner amidst a decade-old environmental dispute in Limassol. Kadis, a conservation biologist, has extensive ministerial experience spanning 25 years.
Hims & Hers Health Inc. shares surged by up to 18%, reaching record highs, following the news of President-elect Donald Trump nominating Marty Makary to lead the FDA. Hunterbrook Media highlighted that Makary could be a significant ally for the company, which is involved in selling compounded GLP-1 weight loss drugs. Hunterbrook Capital has shifted its position to long Hims shares, reversing a previous short bet.
SCHOTT Pharma AG & Co KGaA, based in Germany, specializes in advanced drug containment and delivery solutions for the pharmaceutical and biotechnology sectors. The company offers a comprehensive range of products, including pharmaceutical syringes, cartridges, vials, and ampoules, positioning itself as a leader in the injectable drugs market. UBS has maintained a neutral rating on the company.
18:30 25.11.2024
Trending
Subcategory:
Countries:
Companies:
Currencies:
People:

Machinary offers a groundbreaking, modular, and customizable solution that provides advanced financial news and statistical analysis. Our platform goes beyond traditional quantitative analysis, offering users a comprehensive understanding of real-time market dynamics, event detection, and risk analysis.

Address

Newsletter

© 2025 by Machinary.com - Version: 1.0.0.0. All rights reserved

Layout

Color mode

Theme mode

Layout settings